Hepatocyte (Immunohistochemistry) Antibody
Specific Marker for Hepatocellular Carcinoma Diagnosis
The Hepatocyte antibody, developed by Talent Biomedical, is a specialized immunohistochemistry (IHC) reagent designed for the detection of hepatocyte-specific antigens in liver tissues.
This antibody plays a crucial role in identifying hepatocellular differentiation and is widely used for distinguishing Hepatocellular Carcinoma (HCC) from metastatic clear cell tumors and other malignancies.
In IHC staining, Hepatocyte antibody produces strong cytoplasmic brown staining in hepatocytes and hepatocellular carcinoma cells, confirming its high specificity and sensitivity for liver-origin tumors.
It is also valuable in diagnosing Hepatoblastoma (Embryonal type) and differentiating it from other small round cell tumors in pediatric pathology.
🌐 Fardad Azma Rad Co.
Fardad Azma Rad Co. is the exclusive representative of Talent Biomedical Technology Co., Ltd. (China) in Iran and the authorized supplier of high-quality IHC antibodies, including Hepatocyte.
With a strong focus on diagnostic accuracy, product quality, and compliance with international standards,
Fardad Azma Rad provides innovative solutions to pathology laboratories and cancer diagnostic centers across Iran.
🔬 Features and Benefits
-
Specific marker for hepatocytes and hepatocellular differentiation
-
Useful in diagnosing Hepatocellular Carcinoma (HCC) and differentiating it from metastatic tumors
-
Cytoplasmic positive staining in normal and neoplastic liver cells
-
Fully compatible with FFPE tissue samples and DAB-based IHC detection
-
Certified CE-IVD and produced under rigorous quality control standards
💡 Diagnostic Applications
-
Diagnosis of Hepatocellular Carcinoma (HCC)
-
Differentiation of Hepatoblastoma from other pediatric tumors
-
Identification of liver-origin metastases
-
Research on liver-specific antigens and hepatocellular tumors

There are no reviews yet.